Grifols (GIKLY) Current Leases (2016 - 2023)
Grifols (GIKLY) posted Current Leases of $115.2 million for Q4 2023, up 10.35% quarter-over-quarter from $104.4 million in Q4 2022, and up 10.35% year-on-year from $104.4 million in Q4 2022.
Grifols (GIKLY) Current Leases (2016 - 2023) Analysis & Trends
Grifols (GIKLY) has reported Current Leases for 9 consecutive years, with $115.2 million the latest figure, recorded in Q4 2023.
- Current Leases for Q4 2023 came in at $115.2 million, up 10.35% year-over-year; the trailing twelve-month figure through Dec 2023 was $115.2 million (up 10.35% YoY), and the FY2023 annual result was $115.2 million, up 10.35% from the prior year.
- Current Leases was $115.2 million for Q4 2023 at Grifols, up from $104.4 million in the prior quarter.
- Over five years, Current Leases peaked at $115.2 million in Q4 2023 and troughed at $49.2 million in Q4 2019.
- Average Current Leases over 5 years is $75.0 million, with a median of $55.6 million recorded in 2021.
- Year-over-year, Current Leases surged 1186.21% in 2019 and rose 3.44% in 2020.
- Over 5 years, Current Leases stood at $49.2 million in 2019, then climbed by 3.44% to $50.8 million in 2020, then increased by 9.28% to $55.6 million in 2021, then soared by 87.96% to $104.4 million in 2022, then grew by 10.35% to $115.2 million in 2023.
- Per Business Quant data, the three most recent Current Leases figures were $115.2 million in Q4 2023, $104.4 million in Q4 2022, and $55.6 million in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | - |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | 271.00 Mn |
| 10 | Grifols | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 115.23 Mn |
| Dec 31, 2022 | 104.43 Mn |
| Dec 31, 2021 | 55.56 Mn |
| Dec 31, 2020 | 50.84 Mn |
| Dec 31, 2019 | 49.15 Mn |
| Dec 31, 2018 | 3.82 Mn |
| Dec 31, 2017 | 4.64 Mn |
| Dec 31, 2016 | 4.17 Mn |